Amyloid-β neurotoxicity restricts glucose window for neuronal survival in rat hippocampal slice cultures

Experimental Gerontology
Xiaonan WangTakashi Sakurai

Abstract

Diabetes may increase the risk of Alzheimer's disease (AD). However, a preventive strategy to combat cognitive decline in diabetic elderly with preexisting AD has remained unknown. The aim of this study was to determine the effects of metabolic perturbation on amyloid-β (Aβ) neurotoxicity and the optimal glucose range for improved neuronal survival, which is referred to as the "glucose window". Organotypic hippocampal slice cultures were incubated in either normoglycemic or hyperglycemic medium for 48 h, and subsequently treated in experimental media containing 0-30 mM glucose, with and without Aβ(25-35). Neuronal survival was evaluated by the propidium iodide method. Aβ neurotoxicity was exacerbated during hypoglycemia/hyperglycemia (≦2 mM/≧30 mM) without Aβ and ≦3 mM/≧20 mM with Aβ. ROS elevated in the respective glucose ranges and supplementation of ROS scavengers effectively improved neuronal survival. Interestingly, a sharp and sudden drop in glucose levels from preceding hyperglycemia further increased Aβ neurotoxicity. Supplementation of pyruvate protected exacerbated Aβ neurotoxicity. These results indicate that increased oxidative stress during severe hypoglycemia, hyperglycemia and fluctuation of blood glucose enhance...Continue Reading

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.